Package 66267-389-90

Brand: terazosin

Generic: terazosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 66267-389-90
Digits Only 6626738990
Product NDC 66267-389
Product ID 66267-389_1fa6d444-4cb4-0343-e063-6394a90aa95a
Description

90 CAPSULE in 1 BOTTLE (66267-389-90)

Marketing

Marketing Status
Marketed Since 2016-11-09
Brand terazosin
Generic terazosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Terazosin ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1fa6d444-4cb4-0343-e063-6394a90aa95a", "openfda": {"upc": ["0366267389303"], "unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["40e5ae44-708a-15a3-e054-00144ff8d46c"], "manufacturer_name": ["NuCare Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (66267-389-90)", "package_ndc": "66267-389-90", "marketing_start_date": "20161109"}], "brand_name": "Terazosin", "product_id": "66267-389_1fa6d444-4cb4-0343-e063-6394a90aa95a", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "66267-389", "generic_name": "Terazosin Hydrochloride", "labeler_name": "NuCare Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20041220", "listing_expiration_date": "20261231"}